Task: Answer the multiple-choice question.
Query: Which drug exhibits a -3.214\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a Cc1ccc(N2CC(C(=O)N3CCOCC3)CC2=O)cc1C
b COc1ccc(-n2cnc3c(cnn3CCC#N)c2=N)cc1
c Cc1ccc(NC(=O)C(C)c2cccc(C(=O)c3ccccc3)c2)cc1
d COc1ccc(CNC(=O)N2CCN(c3ccccc3OC)CC2)cc1
Answer: b. COc1ccc(-n2cnc3c(cnn3CCC#N)c2=N)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(-n2cnc3c(cnn3CCC#N)c2=N)cc1
COc1ccc(-n2cnc3c(cnn3CCC#N)c2=N)cc1
3-[4-imino-5-(4-methoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]propanenitrile